Cargando…
Vaccine-induced immune thrombocytopaenia and thrombosis (VITT) after COVID-19 vaccination
COVID-19 represents a global health emergency, causing significant morbidity and mortality. Multiple vaccines have been distributed worldwide to control the spread of this pandemic. Several reports of thrombosis and thrombocytopaenia have been described after vaccination. These have been termed vacc...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121433/ https://www.ncbi.nlm.nih.gov/pubmed/35589271 http://dx.doi.org/10.1136/bcr-2021-247346 |
_version_ | 1784711147686985728 |
---|---|
author | Ribeiro, Maria Inês Pimenta, Inês Conde, Inês Gonzalez, Filipe André |
author_facet | Ribeiro, Maria Inês Pimenta, Inês Conde, Inês Gonzalez, Filipe André |
author_sort | Ribeiro, Maria Inês |
collection | PubMed |
description | COVID-19 represents a global health emergency, causing significant morbidity and mortality. Multiple vaccines have been distributed worldwide to control the spread of this pandemic. Several reports of thrombosis and thrombocytopaenia have been described after vaccination. These have been termed vaccine-induced immune thrombocytopaenia and thrombosis (VITT). We report a fatal case of VITT after receiving the first dose of Ad26.COV2.S vaccine. A man in his 30s developed thrombocytopaenia, massive haemoperitoneum due to spleen rupture and extensive portal and femoral vein thrombosis. The patient rapidly developed multiple organ failure and died. We attributed this condition to the vaccine due to the temporal relationship, presence of thrombosis and thrombocytopaenia, high levels of platelet factor 4 antibodies and exclusion of other diagnoses. Healthcare providers should be aware of such rare but fatal complications of COVID-19 immunisation, as early diagnosis of VITT may improve prognosis by allowing timely appropriate treatment. |
format | Online Article Text |
id | pubmed-9121433 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-91214332022-06-04 Vaccine-induced immune thrombocytopaenia and thrombosis (VITT) after COVID-19 vaccination Ribeiro, Maria Inês Pimenta, Inês Conde, Inês Gonzalez, Filipe André BMJ Case Rep Case Reports: Adverse drug reactions and complications COVID-19 represents a global health emergency, causing significant morbidity and mortality. Multiple vaccines have been distributed worldwide to control the spread of this pandemic. Several reports of thrombosis and thrombocytopaenia have been described after vaccination. These have been termed vaccine-induced immune thrombocytopaenia and thrombosis (VITT). We report a fatal case of VITT after receiving the first dose of Ad26.COV2.S vaccine. A man in his 30s developed thrombocytopaenia, massive haemoperitoneum due to spleen rupture and extensive portal and femoral vein thrombosis. The patient rapidly developed multiple organ failure and died. We attributed this condition to the vaccine due to the temporal relationship, presence of thrombosis and thrombocytopaenia, high levels of platelet factor 4 antibodies and exclusion of other diagnoses. Healthcare providers should be aware of such rare but fatal complications of COVID-19 immunisation, as early diagnosis of VITT may improve prognosis by allowing timely appropriate treatment. BMJ Publishing Group 2022-05-18 /pmc/articles/PMC9121433/ /pubmed/35589271 http://dx.doi.org/10.1136/bcr-2021-247346 Text en © BMJ Publishing Group Limited 2022. No commercial re-use. See rights and permissions. Published by BMJ. |
spellingShingle | Case Reports: Adverse drug reactions and complications Ribeiro, Maria Inês Pimenta, Inês Conde, Inês Gonzalez, Filipe André Vaccine-induced immune thrombocytopaenia and thrombosis (VITT) after COVID-19 vaccination |
title | Vaccine-induced immune thrombocytopaenia and thrombosis (VITT) after COVID-19 vaccination |
title_full | Vaccine-induced immune thrombocytopaenia and thrombosis (VITT) after COVID-19 vaccination |
title_fullStr | Vaccine-induced immune thrombocytopaenia and thrombosis (VITT) after COVID-19 vaccination |
title_full_unstemmed | Vaccine-induced immune thrombocytopaenia and thrombosis (VITT) after COVID-19 vaccination |
title_short | Vaccine-induced immune thrombocytopaenia and thrombosis (VITT) after COVID-19 vaccination |
title_sort | vaccine-induced immune thrombocytopaenia and thrombosis (vitt) after covid-19 vaccination |
topic | Case Reports: Adverse drug reactions and complications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121433/ https://www.ncbi.nlm.nih.gov/pubmed/35589271 http://dx.doi.org/10.1136/bcr-2021-247346 |
work_keys_str_mv | AT ribeiromariaines vaccineinducedimmunethrombocytopaeniaandthrombosisvittaftercovid19vaccination AT pimentaines vaccineinducedimmunethrombocytopaeniaandthrombosisvittaftercovid19vaccination AT condeines vaccineinducedimmunethrombocytopaeniaandthrombosisvittaftercovid19vaccination AT gonzalezfilipeandre vaccineinducedimmunethrombocytopaeniaandthrombosisvittaftercovid19vaccination |